講演情報
[BP-2]腎性低尿酸血症の原因遺伝子URAT1/SLC22A12の日本人30,685名における臨床遺伝学的解析:実際的診断に向けて
○河村 優輔1, 中山 昌喜1, 清水 聖子1, 豊田 優1, 染谷 真澄1, 小田 悠太1, 鳥羽 美帆1, 川口 真1, 鈴木 聡子2, 岩澤 聡子2, 中島 宏2, 高田 龍平3, 角田 正史2, 有澤 幸吉4, 嶽崎 俊郎5, 田中 恵太郎6, 市田 公美7, 若井 建志8, 四ノ宮 成祥1, 松尾 洋孝1 (1.防衛医科大学校 分子生体制御学講座, 2.防衛医科大学校 衛生学公衆衛生学講座, 3.東京大学 医学部附属病院薬剤部, 4.徳島大学大学院医歯薬学研究部医科学部門社会医学系 予防医学, 5.鹿児島大学大学院医歯学総合研究科 国際離島医療学, 6.佐賀大学医学部 社会医学講座 予防医学, 7.東京薬科大学 病態生理学教室, 8.名古屋大学大学院医学系研究科 予防医学)
※12月15日(木)と16日(金)で同一演題の発表を行います。
Renal hypouricemia (RHUC) is an inherited disorder caused by nonfunctional variants of URAT1/SLC22A12, which encodes a urate reabsorption transporter. W258X (rs121907892) and R90H (rs121907896) are known to be the two commonest nonfunctional variants of URAT1 (NFV-URAT1) for Japanese patients with RHUC. RHUC is relatively frequent in Japanese, but no studies have been reported for the distribution of NFV-URAT1 in hypouricemic individuals (serum uric acid, SUA ≦ 3.0 mg/dl; normal range: 3.0~7.0 mg/dl) in a large population. Our investigation for 30,685 Japanese demonstrated that 0.97% of males and 6.94% of females were hypouricemic individuals. With 1,040 hypouricemic individuals whose DNA were available, we genotyped NFV-URAT1 and revealed that 85.7% (male) and 73.7% (female) in hypouricemia (SUA ≦ 2.0 mg/dl) were suspected as RHUC due to having at least one allele of NFV-URAT1. Furthermore, the effects of NFV-URAT1 on SUA and fractional excretion of uric acid (FEUA; normal range: 5.5~11.1%), the characteristic clinical parameters of RHUC, were evaluated in 2,240 individuals whose urinary data were available. As a result, NFV-URAT1 alleles significantly increased FEUA and decreased SUA in both sexes. Especially, FEUA was increased up to 45% and SUA was decreased to less than 1.0 mg/dl in those with two alleles. Together with previous reports, we herein propose more practical diagnosis of RHUC based on the specific distribution patterns of FEUA and SUA data, which leads to predict the number of nonfunctional variants of causative genes for RHUC even before genetic tests.